Solorank.ai
Login

Cached score snapshot

US.SYK · Stryker Corporation

110分制 68.8/110；5D動能v2 8/50；排序分 76.8/160 · Incomplete inputs

Back to ranking Open volume snapshot
Ranking score 76.8/160
Main score 68.8/110
5D momentum v2 8/50
Rank #69
Setup grade D 35.5

Score breakdown

謹慎買入

Medium twelvedata

Score and price trend

D 35.5 Money flow A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 05-13 07-17 08-19 09-03 09-18 $281.98$340.10$398.21 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.578 · anchors 120 -0.49% -2.22% / +3.02% 43.8% 6.3% Actual +2.41% · vs median +2.90% · inside 25-75 band
30D observation +6.49% +3.54% / +12.36% 88.8% 2.5% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.02% -2.31% / +2.83% 50.6% 4.4% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-05-13 → 2026-09-18 · 173 archived points · 1 Improving turn signal · 10 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 76.8
Display grade 謹慎買入
Model version cursor_18_27_news_v2_160
Main score 68.8/110 (謹慎買入)
5D momentum v2 8/50 (弱)
Score with momentum v2 76.8/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Incomplete score

此 snapshot 已計出評分，但以下輸入仍不完整；缺失維度以 0 分處理，請留意 audit 明细。

  • VIX_MISSING: VIX market context is required for market environment scoring

Market inputs

Bar count 60
ma20 330.1095
ma50 319.5982
close 339.03
prevClose 337.43
avgVolume20 2465425
volumeRatio 0.75
changePercent 0.47

Metrics snapshot

close 339.03
volume 1845900
changePercent 0.47

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 68.8/110
Main rating 謹慎買入
5D momentum v2 8/50
Score with momentum v2 76.8/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.5/5 · 良好
Dimension score 3.5/5
Dimension grade 良好

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.6
debtPoints 0.4
marginPoints 0.4
turnoverUsdM 625.8155
volumePoints 0.5
revenuePoints 0.4
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 14/20 · 良好
Dimension score 14/20
Dimension grade 良好

Sub-items

cmfPoints 2.4
mfiPoints 1.6
obvPoints 4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.SYK
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 7.8/15 · 較差
Dimension score 7.8/15
Dimension grade 較差

Sub-items

vix

score 0

details

source twelvedata+fred
missing true
vixClose n/a

trend

score 3.4

details

qqq

ma20 700.3395
ma50 714.5674
name QQQ
close 723.03
points 1.4

spy

ma20 750.1725
ma50 747.189
name SPY
close 773.26
points 2
source twelvedata+fred
atrPct 3.4523
atrPoints 2
cciPoints 2.4
vixPoints 0
marketTrendPoints 3.4

催化劑 — 10/20 · 較差
Dimension score 10/20
Dimension grade 較差

Sub-items

catalyst

score 10

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 2
catalystPoints 10

風險管理 — 6.5/10 · 一般
Dimension score 6.5/10
Dimension grade 一般

Sub-items

position

score 1.3

details

atrPct 3.4523
turnoverUsdM 625.8155
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.SYK
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 315.6214

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 6.9
take_profit_price 365.7158
target_multiplier 1.9
technical_strength 1.8
take_profit_percent 7.9
positionPoints 1.3
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.9046
diversificationPoints 2

技術信號 — 19/30 · 一般
Dimension score 19/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 0.9
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 0.9
vcp_reason 站上MA50；升放量(近10日2日)；Ready=N；Confirm=Y

vcp_metrics

up_days 6
vol_ref 2608973.3333
down_days 3
vcp_ready false
above_ma50 true
avg_vol_10 2599790
avg_vol_20 2509360
avg_vol_30 2608973.3333
range_pct_10 0.1029
range_pct_20 0.1356
range_pct_30 0.1356
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 2
breakout_20d_ok false
vol_ratio_10_30 0.9965
dist_to_20d_high 0.0382
down_shrink_days 0
breakout_level_20d 352.49
vcp_breakout_confirm true
contraction_ratio_10_30 0.7587
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.4
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 0.4

情緒分析 — 8/10 · 優秀
Dimension score 8/10
Dimension grade 優秀

Sub-items

sentiment

score 8

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 7
sentimentScoreRaw 2.1

sentimentData

raw {"id":141104957,"url":"https://finnhub.io/api/news?id=9849996268e6ca0377aecd342af41d4b51c2d6d2acf14fa9f72988951fdbab6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"CEO Lobo discusses 9% organic sales growth and margin expansion amid cybersecurity recovery.","category":"company","datetime":1785802582,"headline":"Stryker (SYK) Q2 2026 Earnings Call Transcript"}, {"id":141097760,"url":"https://finnhub.io/api/news?id=80e1dd08af4122889d88473a16bce0918659f15f36bd69017922b57bb9b5f136","image":"https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp","source":"ChartMill","related":"SYK","summary":"Discover why Stryker (SYK) passes a dividend screen: sustainable 1.01% yield, 7.89% growth, 38.99% payout, strong profitability. Health rating meets bar.","category":"company","datetime":1785750053,"headline":"Stryker (NYSE:SYK): A Dividend Quality Play Built on Sustainability"}, {"id":141090573,"url":"https://finnhub.io/api/news?id=9dbefeaf373d9024ee65846476362487848dd3b3f07e6fe8bb7dabe7667947ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (SYK) is back in focus after its second quarter 2026 earnings, reporting sales of US$6.59b and net income of US$1.28b, alongside a sharp market reaction to the release. See our latest analysis for Stryker. The 1 day share price return of Stryker fell 6.42% on the earnings release, which pulled the year to date share price return down 6.46%, while the 5 year total shareholder return of 30.66% still reflects longer term gains. If Stryker’s move has you reassessing healthcare exposure,...","category":"company","datetime":1785633074,"headline":"Is Stryker (SYK) Undervalued As Earnings Trigger A Fresh Valuation Question?"}, {"id":141088416,"url":"https://finnhub.io/api/news?id=54578ceeaf964b6f31c57ee7cdaffbe27b14fd3400769e823cb4e53c7b4dfe57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker Corporation’s recently reported Q2 2026 results showed sales rising to US$6,589 million and net income to US$1,276 million, with both basic and diluted EPS from continuing operations increasing compared with the prior year period. Management also highlighted 9% organic sales growth, recovery progress after a March cyberattack that disrupted operations, and a slight increase to full-year adjusted EPS guidance while planning to resume share repurchases. We will now examine how this...","category":"company","datetime":1785600733,"headline":"How Strong Q2 Earnings, Raised Guidance and Cyber Recovery Will Impact Stryker (SYK) Investors"}, {"id":141084897,"url":"https://finnhub.io/api/news?id=b6978582991385153a02d491825539798caf4e831e99c586ea1b284895d2bece","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share was 5.8% above analysts’ consensus estimates.","category":"company","datetime":1785555117,"headline":"SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion"}, {"id":141079101,"url":"https://finnhub.io/api/news?id=6e1444ccc3ac0c6ab45925f0bd4567205c2db2067d2d5fb848c2ee757ad501eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results that showed revenue that only met Wall Street's expectations and organic sales growth that missed forecasts.","category":"company","datetime":1785511437,"headline":"Why Stryker (SYK) Shares Are Plunging Today"}, {"id":141079102,"url":"https://finnhub.io/api/news?id=693d7da201dd6ee1737f170709fd5edad838d6fb56b43a75a77dcfa9ba5d0007","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.","category":"company","datetime":1785504660,"headline":"SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery"}, {"id":141075609,"url":"https://finnhub.io/api/news?id=3d725f68363f48a7fdbf65bd22e09ddad123f3e16ed50064ac1689cb30755331","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker Corp (SYK) delivers robust Q2 2026 results with 17.9% adjusted EPS growth, while navigating supply disruptions and narrowing full-year guidance.","category":"company","datetime":1785474263,"headline":"Stryker Corp (SYK) (Q2 2026) Earnings Call Highlights: Strong 9% Organic Growth and Raised ..."}
raw_source {"id":141157889,"url":"https://finnhub.io/api/news?id=c0352c42a3ef8e0c8c3348709ded75f12dd8c95242bad3e9a9ae7d785e605ddc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Intuitive Surgical has shed a third of its value while its robotic surgery peers barely flinched, and Wall Street's most bullish analyst sees an outcome that would leave anyone who sold near the bottom regretting it.","category":"company","datetime":1786187149,"headline":"The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%"}, {"id":141160407,"url":"https://finnhub.io/api/news?id=528a84599182908bd0e04f9d3370d0a4f48c0d445d276e45da45e040f2621304","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536","source":"Benzinga","related":"SYK","summary":"Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.02% on an annualized basis producing an average annual return of 10.41%. Currently, Stryker has a market capitalization of $129.84 billion.","category":"company","datetime":1786122932,"headline":"If You Invested $100 In Stryker Stock 20 Years Ago, You Would Have This Much Today"}, {"id":141121339,"url":"https://finnhub.io/api/news?id=f77b1271cdec6b5d0601f6c02a1fb264886f20ef1e4571a81b76f197cf0e91d8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer","category":"company","datetime":1785936840,"headline":"Stryker declares an $0.88 per share quarterly dividend"}, {"id":141104957,"url":"https://finnhub.io/api/news?id=9849996268e6ca0377aecd342af41d4b51c2d6d2acf14fa9f72988951fdbab6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"CEO Lobo discusses 9% organic sales growth and margin expansion amid cybersecurity recovery.","category":"company","datetime":1785802582,"headline":"Stryker (SYK) Q2 2026 Earnings Call Transcript"}, {"id":139932823,"url":"https://finnhub.io/api/news?id=d08bec2c986ad84c660e7b6cf19364768850055926e7b5b30c3a247ae5aa2883","image":"","source":"Benzinga","related":"SYK","summary":"","category":"company","datetime":1785766428,"headline":"Intuitive Surgical shares are trading higher after the company reported better-than-expected Q1 financial results."}, {"id":141101827,"url":"https://finnhub.io/api/news?id=d68930e6e25991562657a9574754249d8201846073976719a9fff78b25c57d9b","image":"","source":"Benzinga","related":"SYK","summary":"Citizens analyst David Turkaly maintains Stryker (NYSE:SYK) with a Market Outperform and lowers the price target from $440 to $400.","category":"company","datetime":1785751744,"headline":"Citizens Maintains Market Outperform on Stryker, Lowers Price Target to $400"}, {"id":141097760,"url":"https://finnhub.io/api/news?id=80e1dd08af4122889d88473a16bce0918659f15f36bd69017922b57bb9b5f136","image":"https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp","source":"ChartMill","related":"SYK","summary":"Discover why Stryker (SYK) passes a dividend screen: sustainable 1.01% yield, 7.89% growth, 38.99% payout, strong profitability. Health rating meets bar.","category":"company","datetime":1785750053,"headline":"Stryker (NYSE:SYK): A Dividend Quality Play Built on Sustainability"}, {"id":141093867,"url":"https://finnhub.io/api/news?id=f313d2251dc4aeb66a33544f649f0fbe55f30728f01035fcaef9d6a2fa471782","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed current Controller and Chief Accounting Officer Mary Wilcox following her retirement. Zieselman brings experience from Surgery Partners Inc., Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya Inc., and is a licensed CPA. Solventum enters this leadership change with its stock at $85.44 and a value score of 5, which can help...","category":"company","datetime":1785679682,"headline":"Solventum (SOLV) Appoints Neil Zieselman As New Chief Accounting Officer"}, {"id":141090573,"url":"https://finnhub.io/api/news?id=9dbefeaf373d9024ee65846476362487848dd3b3f07e6fe8bb7dabe7667947ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (SYK) is back in focus after its second quarter 2026 earnings, reporting sales of US$6.59b and net income of US$1.28b, alongside a sharp market reaction to the release. See our latest analysis for Stryker. The 1 day share price return of Stryker fell 6.42% on the earnings release, which pulled the year to date share price return down 6.46%, while the 5 year total shareholder return of 30.66% still reflects longer term gains. If Stryker’s move has you reassessing healthcare exposure,...","category":"company","datetime":1785633074,"headline":"Is Stryker (SYK) Undervalued As Earnings Trigger A Fresh Valuation Question?"}, {"id":141088416,"url":"https://finnhub.io/api/news?id=54578ceeaf964b6f31c57ee7cdaffbe27b14fd3400769e823cb4e53c7b4dfe57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker Corporation’s recently reported Q2 2026 results showed sales rising to US$6,589 million and net income to US$1,276 million, with both basic and diluted EPS from continuing operations increasing compared with the prior year period. Management also highlighted 9% organic sales growth, recovery progress after a March cyberattack that disrupted operations, and a slight increase to full-year adjusted EPS guidance while planning to resume share repurchases. We will now examine how this...","category":"company","datetime":1785600733,"headline":"How Strong Q2 Earnings, Raised Guidance and Cyber Recovery Will Impact Stryker (SYK) Investors"}, {"id":141084897,"url":"https://finnhub.io/api/news?id=b6978582991385153a02d491825539798caf4e831e99c586ea1b284895d2bece","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share was 5.8% above analysts’ consensus estimates.","category":"company","datetime":1785555117,"headline":"SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion"}, {"id":141084898,"url":"https://finnhub.io/api/news?id=f664948358320b7072ec63f7a4f232d5cb083af6b12cdfe5111e88f186be9a04","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (NYSE:SYK) reported 9% organic sales growth in the second quarter of 2026 and adjusted earnings per share growth of 17.9%, as the medical technology company continued recovering from a cybersecurity incident that disrupted operations earlier in the year. Chair and CEO Kevin Lobo said the co","category":"company","datetime":1785553419,"headline":"Stryker Q2 Earnings Call Highlights"}, {"id":141081084,"url":"https://finnhub.io/api/news?id=70bbcce77128ce60408559bc0eff0eb1c5a69e0b368ceaf48afb23f8f90d3659","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.","category":"company","datetime":1785524701,"headline":"Stay informed with the top movers within the S&P500 index on Friday."}, {"id":141079654,"url":"https://finnhub.io/api/news?id=dc3ff60c01a4cba8c16b37a9d68c917c01a4881bda5a38ec734feab622f76ce3","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.","category":"company","datetime":1785515701,"headline":"Friday's session: top gainers and losers in the S&P500 index"}, {"id":141088034,"url":"https://finnhub.io/api/news?id=091e291322d839a74e3ff99817f04cbc67876f2b1099f6fc55fe8b4d55ef1aad","image":"","source":"Benzinga","related":"SYK","summary":"RBC Capital analyst Kendall Au maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $435 to $420.","category":"company","datetime":1785512976,"headline":"RBC Capital Maintains Outperform on Stryker, Lowers Price Target to $420"}, {"id":141079101,"url":"https://finnhub.io/api/news?id=6e1444ccc3ac0c6ab45925f0bd4567205c2db2067d2d5fb848c2ee757ad501eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results that showed revenue that only met Wall Street's expectations and organic sales growth that missed forecasts.","category":"company","datetime":1785511437,"headline":"Why Stryker (SYK) Shares Are Plunging Today"}, {"id":141088035,"url":"https://finnhub.io/api/news?id=e2e2d816fb0ebe46d62fd30241fd1096e427f4fdb38399f659a7ed60c09124cc","image":"","source":"Benzinga","related":"SYK","summary":"JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $400 to $350.","category":"company","datetime":1785508582,"headline":"JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $350"}, {"id":141078388,"url":"https://finnhub.io/api/news?id=709f67f86ab747d0315d9411a2d452a1aa73a192bfaa79693c1ad37daa9e1c90","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"SYK","summary":"Let's have a look at the S&P500 gap up and gap down stocks in today's session.","category":"company","datetime":1785508501,"headline":"These S&P500 stocks are gapping in today's session"}, {"id":141079102,"url":"https://finnhub.io/api/news?id=693d7da201dd6ee1737f170709fd5edad838d6fb56b43a75a77dcfa9ba5d0007","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.","category":"company","datetime":1785504660,"headline":"SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery"}, {"id":141077642,"url":"https://finnhub.io/api/news?id=3223cbf246df2f33c69539037f774a50260cd33d10286f045a518ad8062cad57","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"SYK","summary":"Discover the top S&P500 movers in Friday's pre-market session and stay informed about market dynamics.","category":"company","datetime":1785501301,"headline":"Get insights into the top movers in the S&P500 index of Friday's pre-market session."}, {"id":141080377,"url":"https://finnhub.io/api/news?id=ebf5302d3fb61d848b9318d2fb7161d75f2dfb97d79c0c3fcbc56679c65157a8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.","category":"company","datetime":1785498800,"headline":"Stryker catching up on orders, manufacturing after cyberattack"}, {"id":141077283,"url":"https://finnhub.io/api/news?id=b5d6ed3a1f9c19e6aa2d7ed38d14a89d15abccf4e60653931114cbaf20826ee9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker was hit by a cyberattack that disrupted its global operations in March 2026.","category":"company","datetime":1785497028,"headline":"Stryker nets $6.6bn revenue in Q2; highlights resilience following cyberattack"}, {"id":141088036,"url":"https://finnhub.io/api/news?id=1b5ab335d27aff234262b61781f47c128f6b86ebac32369030c8041cc039064b","image":"","source":"Benzinga","related":"SYK","summary":"Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $420 to $390.","category":"company","datetime":1785495130,"headline":"Piper Sandler Maintains Overweight on Stryker, Lowers Price Target to $390"}, {"id":141078468,"url":"https://finnhub.io/api/news?id=f9384096c9e2ec130648bc3a76d285228a71b0c2a31d7243ff37ac4708154cff","image":"","source":"Benzinga","related":"SYK","summary":"Truist Securities analyst Richard Newitter maintains Stryker (NYSE:SYK) with a Hold and raises the price target from $330 to $340.","category":"company","datetime":1785490094,"headline":"Truist Securities Maintains Hold on Stryker, Raises Price Target to $340"}, {"id":141078421,"url":"https://finnhub.io/api/news?id=6dc628efceee58f8f06074c12188171787de522b940387d97752b47b6745b3a6","image":"https://cdn.benzinga.com/files/images/story/2026/07/31/Cupertino--California--September-25--202.jpg?width=2048&height=1536","source":"Benzinga","related":"SYK","summary":"U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.","category":"company","datetime":1785484996,"headline":"Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session"}, {"id":141078470,"url":"https://finnhub.io/api/news?id=acf0bbaa6753c43c4b00ed1d1b6791d23dfcd48e79c29b5eed422e206ecf7914","image":"","source":"Benzinga","related":"SYK","summary":"BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $371 to $358.","category":"company","datetime":1785476106,"headline":"BTIG Maintains Buy on Stryker, Lowers Price Target to $358"}, {"id":141075609,"url":"https://finnhub.io/api/news?id=3d725f68363f48a7fdbf65bd22e09ddad123f3e16ed50064ac1689cb30755331","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker Corp (SYK) delivers robust Q2 2026 results with 17.9% adjusted EPS growth, while navigating supply disruptions and narrowing full-year guidance.","category":"company","datetime":1785474263,"headline":"Stryker Corp (SYK) (Q2 2026) Earnings Call Highlights: Strong 9% Organic Growth and Raised ..."}, {"id":141072966,"url":"https://finnhub.io/api/news?id=f94904855a6beaf664103c9538e9891d54fcd035cad74bffa4c28a3ca723c1a6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.","category":"company","datetime":1785448803,"headline":"Stryker (SYK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates"}, {"id":141073948,"url":"https://finnhub.io/api/news?id=2bf87100b0be4ace6f9bb6fd5739de24834776b90e8c0a9111f2ff1feb67b47f","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"SYK","summary":"Stryker Corporation (SYK) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDTCompany ParticipantsKevin Lobo - Chairman & CEONick Mead - Vice President of...","category":"company","datetime":1785447195,"headline":"Stryker Corporation (SYK) Q2 2026 Earnings Call Transcript"}, {"id":141072967,"url":"https://finnhub.io/api/news?id=b87882a1733a32a94b94a807ef31827915068c20b41d6dc80024bd57afa87e23","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (SYK) delivered earnings and revenue surprises of +6.65% and +0.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1785446704,"headline":"Stryker (SYK) Q2 Earnings and Revenues Beat Estimates"}, {"id":141070794,"url":"https://finnhub.io/api/news?id=f8d1c849bf50f0e7ed2bab5907315b69ff748fb261be59d615f88c9467b4b9f8","image":"https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp","source":"ChartMill","related":"SYK","summary":"The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.","category":"company","datetime":1785445501,"headline":"Which S&P500 stocks are moving after the closing bell on Thursday?"}, {"id":141070567,"url":"https://finnhub.io/api/news?id=271cbe3ae8d42a3003c39cf6da1cc6ad0b18ff06988b4893fe364cbc7d9a5942","image":"https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp","source":"ChartMill","related":"SYK","summary":"Stryker Q2 revenue slightly missed estimates but EPS beat; stock fell 9% after-hours amid cyber incident concerns and cautious guidance.","category":"company","datetime":1785444645,"headline":"Stryker (NYSE:SYK) Slips After Q2 Revenue Miss Overshadows Earnings Beat"}, {"id":141071596,"url":"https://finnhub.io/api/news?id=181d14fca24c844c0535538d46d9f10d945ae93483bddf6995e50545afce60f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share was 5.8% above analysts’ consensus estimates.","category":"company","datetime":1785443414,"headline":"Stryker (NYSE:SYK) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops"}, {"id":141071597,"url":"https://finnhub.io/api/news?id=7e11a7d9de1cf122d6661916577ca95d4a22b4502ce141e5a52136cb22075bbd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026: Second Quarter Results Reported net sales increased 9.4% to $6.6 billionOrganic net sales increased 9.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 170 bps to 27.4%Reported EPS increased 44.1% to $3.30Adjusted EPS(1) increased 17.9% to $3.69 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant","category":"company","datetime":1785441900,"headline":"Stryker reports second quarter 2026 operating results"}, {"id":141068403,"url":"https://finnhub.io/api/news?id=f5572ddf3d22d2845f8b0c8b91feb2a909850029630299420001508aaac54c05","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"ISRG is expanding robotic surgery beyond urology as general surgery and newer specialties gain traction, creating fresh avenues for long-term procedure growth.","category":"company","datetime":1785429600,"headline":"Is ISRG Winning the Next Phase of Robotic Surgery Beyond Urology?"}, {"id":141071249,"url":"https://finnhub.io/api/news?id=a6946338722c8fc35da0ad5310a5e929c6886df7814ca18e27bd62ab94a390a1","image":"","source":"Benzinga","related":"SYK","summary":"Stryker (NYSE:SYK) raises FY2026 Adj EPS guidance from $14.90-$15.10 to $14.95-$15.10 vs $14.97 analyst estimate..","category":"company","datetime":1785427679,"headline":"Stryker Raises FY2026 Adj EPS Guidance from $14.90-$15.10 to $14.95-$15.10 vs $14.97 Est"}, {"id":141071250,"url":"https://finnhub.io/api/news?id=37195837c6896f9236190eb1358fbe628e01030bb2ee25e091e7c8fbf2cc4469","image":"","source":"Benzinga","related":"SYK","summary":"Stryker (NYSE:SYK) reported quarterly earnings of $3.69 per share which beat the analyst consensus estimate of $3.49 by 5.73 percent. This is a 17.89 percent increase over earnings of $3.13 per share from the same","category":"company","datetime":1785427605,"headline":"Correction: Stryker Q2 Adj. EPS $3.69 Beats $3.49 Estimate, Sales $6.589B Beat $6.579B Estimate"}, {"id":141054603,"url":"https://finnhub.io/api/news?id=2e1b398d579004081a531279f8ffac40f3827759c8104cd232f4e15a44ec2b33","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.","category":"company","datetime":1785336840,"headline":"Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?"}, {"id":141053281,"url":"https://finnhub.io/api/news?id=c8e5fec55ce152c1ae6354957dc3bbd151dcbca6a9ba72d322bff0b1a932d8bb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"In the world of robotic surgery, one company is both the undisputed leader and the most expensive name on the shelf, forcing investors to ask if operational brilliance is worth the high price of admission.","category":"company","datetime":1785332790,"headline":"The Best House On The Block Costs The Most: ISRG"}, {"id":141043786,"url":"https://finnhub.io/api/news?id=53a07b3ea70afe32c66792b42633c5e5ab98f3c0d30d426365765b844c8aa997","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker has introduced Mako RPS, a robotic handheld system for total knee replacement, expanding its Mako robotics portfolio. The launch extends robotic assistance to a wider range of orthopaedic procedures and care settings. The development highlights Stryker's focus on robotic-assisted surgery and surgeon flexibility in knee replacement. Stryker, traded as NYSE:SYK, is drawing attention with the launch of Mako RPS alongside a share price of $336.74. The stock is up 5.5% over the past week...","category":"company","datetime":1785247667,"headline":"Stryker (SYK) Launches Mako RPS To Bring Robotic Knee Surgery To More Surgeons"}, {"id":141042348,"url":"https://finnhub.io/api/news?id=56f2f285ff59a3a37ef0ce4aefbadc33ee3bcdb7f56f7c7e94741a06e3cf8529","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Intuitive Surgical (NASDAQ:ISRG) trades at $356.83, while the average Wall Street price target sits at $484.40. That leaves roughly a 36% gap between current price and Street consensus. Intuitive builds the da Vinci robotic surgery platform and the Ion lung biopsy system, dominating soft tissue surgical robotics. Wall Street has debated whether that moat holds ... Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685","category":"company","datetime":1785246435,"headline":"Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685"}, {"id":141042644,"url":"https://finnhub.io/api/news?id=7507ca35b1cbe8e76ab6c5b9c089fdd29418dcb58a04e57f6822f7749625c588","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls","category":"company","datetime":1785245664,"headline":"Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls"}, {"id":141035129,"url":"https://finnhub.io/api/news?id=c92ef4a473af545abf93085c0feb833d345113b7ee6e12a65912c65c41f0d0ff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.","category":"company","datetime":1785167220,"headline":"J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?"}, {"id":141035262,"url":"https://finnhub.io/api/news?id=3647e16ddb54bcb74608f6e6fedc1a1a9698d86be7c61a3e3fdbb16221dff9ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"PAHC vs. SYK: Which Stock Is the Better Value Option?","category":"company","datetime":1785166802,"headline":"PAHC vs. SYK: Which Stock Is the Better Value Option?"}, {"id":141033951,"url":"https://finnhub.io/api/news?id=fcecda06d78a64160b71a7c83b72c3f8c835a6e8f5af835e1d1b85f851c8ee0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.","category":"company","datetime":1785158111,"headline":"Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS"}, {"id":141033952,"url":"https://finnhub.io/api/news?id=e1356cc922d24b2065e4fc35f5b4985c2626ea5c847c8e830a021f485c0ba596","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure demand as investors watch for earnings and margin trends.","category":"company","datetime":1785157260,"headline":"Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders"}, {"id":141011008,"url":"https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SYK","summary":"Get the weekly dividend update for Champions, Contenders & Challengers—read about the dividend changes, upcoming ex-dividend dates and pay dates here.","category":"company","datetime":1784916411,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"}, {"id":141005276,"url":"https://finnhub.io/api/news?id=fce891feb90878c9b568365dc8ab8155bd45866a90ca9d2b3a5d6fc1f72863eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.","category":"company","datetime":1784897252,"headline":"Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?"}, {"id":141017280,"url":"https://finnhub.io/api/news?id=76d2787cc2237b397d2f26adc0684909ea937123a4b2b20124117fe4fa5e2b68","image":"https://cdn.benzinga.com/files/images/story/2026/07/24/24-7-2026-111735-thebambooworks-com.jpg?width=2048&height=1536","source":"Benzinga","related":"SYK","summary":"The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses\n\n\n\n\n\n\n\nimage credit: Bamboo Works\n\n\n\nKey Takeaways:\n\n\n\n\nMicroPort MedBot","category":"company","datetime":1784897088,"headline":"MicroPort MedBot To Report First-Ever Profit On Booming Exports"}, {"id":140997733,"url":"https://finnhub.io/api/news?id=74d97e4def4c98d768ccd094d979fd3873c5ca18e7d51d9299d8c49e4fed8b7b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Qualcomm, Intuitive Surgical and Stryker lead today's top analyst reports, spotlighting growth drivers, strategic initiatives and ongoing challenges.","category":"company","datetime":1784817900,"headline":"The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants"}, {"id":140988153,"url":"https://finnhub.io/api/news?id=f12b46768222b60cc0e5cc0ad5a8a82c6ef823fd74cb0af6ee75633f8d102550","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"QUALCOMM is expanding beyond smartphones with growth in automotive, edge AI and data centers, but competition and weak China demand remain key challenges.","category":"company","datetime":1784753640,"headline":"Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker"}, {"id":140974912,"url":"https://finnhub.io/api/news?id=bbdead80568b813174817288369cedcdbc1558cbe69a3fa5d808987e69a9b82d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The market is offering a steep discount on this medical device maker, but the price tag comes with a story about slowing growth. Here’s how to read it.","category":"company","datetime":1784660157,"headline":"Why BSX Stock Hands You So Much Cash Right Now"}, {"id":140974913,"url":"https://finnhub.io/api/news?id=aa203e7f28d79433427fb12950820e559672ed5b69c0e2a20f702bef68a97fcc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.","category":"company","datetime":1784659383,"headline":"ISRG Stock: The Math Hidden In Its Price"}, {"id":140970510,"url":"https://finnhub.io/api/news?id=417bfdbec370b20b7e87a80f159cd76c2d10f705358575971728f4e520ddbf47","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"NZS shifts capital toward AI infrastructure and healthcare leaders","category":"company","datetime":1784636527,"headline":"Nvidia Returns to NZS Growth Fund"}, {"id":140963421,"url":"https://finnhub.io/api/news?id=6ea0dd033658292f48582a592a40caa31066d357172a543dd20d199c2861cc74","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.","category":"company","datetime":1784574905,"headline":"The Robot Maker's Paradox"}, {"id":140963423,"url":"https://finnhub.io/api/news?id=26047126ae59bd8c4eb72c217ec847dd194744894cd020aa98db1bbb6da3a19e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.","category":"company","datetime":1784571665,"headline":"What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?"}, {"id":140958769,"url":"https://finnhub.io/api/news?id=1e780a5396652a26af12c43d63de943d5bbdd6ac1d228864b9cc1b0bedf0fcf1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"LARGO, Fla., July 20, 2026--CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL.","category":"company","datetime":1784545200,"headline":"CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting"}, {"id":140962422,"url":"https://finnhub.io/api/news?id=5580413bb66938372e33afb5c6bebf77eb21224e311db5a3ece505b10699aa95","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536","source":"Benzinga","related":"SYK","summary":"Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.04% on an annualized basis producing an average annual return of 10.3%. Currently, Stryker has a market capitalization of $122.02 billion.","category":"company","datetime":1784543421,"headline":"Here’s How Much You Would Have Made Owning Stryker Stock In The Last 20 Years"}, {"id":140944900,"url":"https://finnhub.io/api/news?id=e77d76f3434f17b44a7271a4b4178cd3a084000ccbc8170e1df151c1706c49f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while market based multiples look closer to fair. Over five years, Stryker has returned 28.3%, which points to steady but not dramatic long term gains for shareholders. New products such as the Mako RPS handheld robotic system can support expectations for future cash...","category":"company","datetime":1784394439,"headline":"Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings"}, {"id":140940547,"url":"https://finnhub.io/api/news?id=c2585392dea75a3bc277f15d8952bba6cd6eb3516ae5a01c7312595cfaa19a1b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move extends the Mako ecosystem beyond robotic-arm systems into handheld robotics, potentially broadening adoption by matching robotic precision with familiar surgical workflows. Next, we’ll explore how expanding the...","category":"company","datetime":1784344509,"headline":"Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK)"}, {"id":140940111,"url":"https://finnhub.io/api/news?id=ebe2202ade933d00e63044350229e08b82e7db86b01a7ae08cdabb4732e1e7be","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements that extends its established Mako orthopaedic robotics portfolio. See our latest analysis for Stryker. The U.S. launch of Mako RPS comes as Stryker’s share price sits at US$319.87 after a recent pullback, with a 30 day share price return of 6.22% but a 1 year total shareholder return that declined 17.02%. This suggests enthusiasm around its...","category":"company","datetime":1784336914,"headline":"Stryker (SYK) Launches Mako RPS As Its Valuation Story Comes Into Focus"}, {"id":140934568,"url":"https://finnhub.io/api/news?id=fcdbb1523ac61c565eff444a9974ae081ef0444ebc3b4e416bbf2d2d7408ab7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.","category":"company","datetime":1784302740,"headline":"Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio"}, {"id":140932973,"url":"https://finnhub.io/api/news?id=0504e442cf7f265bb43b0e44d54c0386af3ed0aa7fd4f592d362e90177bbdfa3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"JNJ beats Q2 estimates and raises 2026 guidance, but shares fall as MedTech misses expectations. Find out what weighed on the unit and what's next.","category":"company","datetime":1784298660,"headline":"J&J Stock Falls Despite Strong Q2 Beat & Higher 2026 View: Here's Why"}, {"id":140111723,"url":"https://finnhub.io/api/news?id=c6a02a2441034d13c97bae14c10063c3d4dedcc3d5c1f87702392bc91f1896e7","image":"","source":"Benzinga","related":"SYK","summary":"","category":"company","datetime":1784291136,"headline":"GE HealthCare Technologies shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS and lowered its FY2026 adjusted EPS guidance."}, {"id":140920976,"url":"https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.","category":"company","datetime":1784210345,"headline":"Why Abbott Stock Is Reimagining Its Future"}, {"id":140919929,"url":"https://finnhub.io/api/news?id=331a94af61a8277087847eb57290e1a52ef46de16da33713fb098788bd0f19de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (NYSE: SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement procedures, further expanding the Mako portfolio into a new category of orthopaedic robotics.","category":"company","datetime":1784207100,"headline":"Stryker expands Mako robotics portfolio with full market release of Mako RPS"}, {"id":140049019,"url":"https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed","image":"","source":"Benzinga","related":"SYK","summary":"","category":"company","datetime":1784205329,"headline":"Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"}, {"id":140912813,"url":"https://finnhub.io/api/news?id=af3b9436f23bb6328aa43e6b3e1faf8d7dd198364bfa6e28cf7cd911df9289f9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.","category":"company","datetime":1784140381,"headline":"The Open Questions On ISRG Stock"}, {"id":140911296,"url":"https://finnhub.io/api/news?id=aee602b293e01bdae62f2d6674938ab67845e74bf45b3536a1bd3aa55fdad064","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Johnson & Johnson stock dipped early Wednesday, though the healthcare giant beat second-quarter forecasts and raised its outlook.","category":"company","datetime":1784134793,"headline":"J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others"}, {"id":140906847,"url":"https://finnhub.io/api/news?id=922de0113b1b98ef15feee5ce7b9d228ed7c895637d059a927c88ef957dcf758","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"When Iranian-linked hackers breached medical device maker Stryker in March 2026, they did not need a sophisticated zero-day exploit to cause chaos. Once inside, they triggered simultaneous factory resets on more than 200,000 corporate devices across 79 countries, grinding order processing, production and shipping to a halt for days. Two months later, Foxconn confirmed that the Nitrogen ransomware group had stolen an alleged 8 terabytes of data from its North American factories, including project","category":"company","datetime":1784102400,"headline":"Independent Testing Shows Which Business Security Products Actually Hold Up When It Matters"}, {"id":140901598,"url":"https://finnhub.io/api/news?id=1c30ec9fc5eaa65b249de9077cf426329d566c616ac5f9591f0e7f9ba8098349","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.","category":"company","datetime":1784058057,"headline":"Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble"}, {"id":140901109,"url":"https://finnhub.io/api/news?id=deff9c90bb7e909239d4818d05eb00911aa88c16bd160a2315a273ea8e21cb70","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.","category":"company","datetime":1784055900,"headline":"Discover which S&P500 stocks are making waves on Tuesday."}, {"id":140901466,"url":"https://finnhub.io/api/news?id=3b28393a5831026f9ac3732237381ea888082eee864a93bb498cf961a423a22f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.","category":"company","datetime":1784052407,"headline":"The Paid-To-Hold Play On ISRG Stock: A 12% Income"}, {"id":140898964,"url":"https://finnhub.io/api/news?id=76a3fb9d03f8bf894bf401ec3d9d7e7a7980e4769b9be8dd004e0986d25fa30d","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.","category":"company","datetime":1784046901,"headline":"These S&P500 stocks are moving in today's session"}, {"id":140897584,"url":"https://finnhub.io/api/news?id=e89def7c0ac59e2c2278d3bdc4ee12a87bb928101e8b6a227c378a65a8572717","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"SYK","summary":"Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.","category":"company","datetime":1784039701,"headline":"What's going on in today's session: S&P500 gap up and gap down stocks"}, {"id":140091407,"url":"https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f","image":"","source":"Benzinga","related":"SYK","summary":"","category":"company","datetime":1784034450,"headline":"Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"}, {"id":140896860,"url":"https://finnhub.io/api/news?id=69cac81872a917b82ac0a4526f38f4b08928a2ae81ab419989126f3ac804ca95","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.","category":"company","datetime":1784033543,"headline":"ISRG Stock: What Does Its Valuation Imply?"}, {"id":140885071,"url":"https://finnhub.io/api/news?id=71b31314daf117ab4b7a113eb37cfe524f5210f5754749ce4767d53f3ef0320c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Opportunities in the nerve repair biomaterials market include advancements in regenerative medicine, rising demand for minimally invasive procedures, and smart biomaterials integration. Growth is driven by increased traumatic brain injuries, aging populations, and regional expansion, especially in Asia-Pacific. Nerve Repair Biomaterials Market Nerve Repair Biomaterials Market Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The \"Nerve Repair Biomaterials Market Report 2026\" has been added to ResearchAn","category":"company","datetime":1783942080,"headline":"Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players"}, {"id":140865362,"url":"https://finnhub.io/api/news?id=190546a100126c6d960166a6da62d4ab071710c348633046d16e808216573c23","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.","category":"company","datetime":1783707000,"headline":"ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?"}, {"id":140857121,"url":"https://finnhub.io/api/news?id=d5da76e3d463a1659eb229b2fb369439662f69c42499cdfd038f9ac17e2e5543","image":"","source":"Fintel","related":"SYK","summary":"","category":"company","datetime":1783645922,"headline":"BMO Capital Initiates Coverage of Stryker (SYK) with Outperform Recommendation"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 7
recomputed_at_score true
sentiment_score_raw 2.1
source_article_count 80
discarded_article_count 60
sentimentPoints 8

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.5 5/110 70% 3.5
資金流 14 20/110 70% 14
市場環境 7.8 15/110 52% 7.8
催化劑 10 20/110 50% 10
風險管理 6.5 10/110 65% 6.5
技術信號 19 30/110 63.33% 19
情緒分析 8 10/110 80% 8

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 8/50
ret_5d 0.0409
max_score 50
max_total 50
raw_total 8
vcp_bonus 0
vol_ratio 0.7356
ret_points 8
vol_points 0
range_ratio 0.7859
volat_points 0
day_range_pct 0.022
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 0
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.3

details

atrPct 3.4523
turnoverUsdM 625.8155
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.SYK
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 315.6214

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 6.9
take_profit_price 365.7158
target_multiplier 1.9
technical_strength 1.8
take_profit_percent 7.9
positionPoints 1.3
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.9046
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.5/5分
資金流分析總分: 14/20分
市場環境分析總分: 7.8/15分
催化劑分析: 10/20分
風險管理總分: 6.5/10分
技術信號分析總分: 19/30分
情緒分析: 8/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 11.7043
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.45
cci
rule Cursor_18.24 CCI bands
level 平衡
score 6
value 49.85
cmf
rule Cursor_18.24 CMF bands
level 輕微流入
score 6
value 0.1479
kdj
d 64.89
j 55.62
k 61.8
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 弱流入
score 4
value 47.52
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 19153100
recentSlope 243350
previousSlope 26930
rsi
value 59.63
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 324.279
position SAR喺價下
distancePct 4.35
previousTrend 上升
ma50
value 319.5982
macd
macd 5.5949
trend 強烈看漲
signal 5.4884
histogram 0.1065
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 329.1212
position 連續5日>VWAP
consecutiveAbove 5
volume
rule Cursor_18.24 volume ratio
level 空升
ratio 0.75
score 2
avgVolume 2465425
currentVolume 1845900
derived
ma20 330.1095
ma50 319.5982
prevClose 337.43
avgVolume10 2547120
avgVolume20 2465425
changePercent 0.47
avgVolumeForScore 2465425
ma_cross
ma20 330.1095
ma50 319.5982
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 329.647
prevMa50 318.9364
spreadPct 3.29
isVolumeBreakout false
bollinger
lower 305.3561
upper 354.8629
position 上半部
rsi_short
value 40.24
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.75

Raw calculation JSON

 
{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.452290367968293,
        "turnoverUsdM": 625.8154751540999,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.SYK",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 315.6214,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 6.9,
      "take_profit_price": 365.7158,
      "target_multiplier": 1.9,
      "technical_strength": 1.8,
      "take_profit_percent": 7.9
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.904580735936586,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 76.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 68.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 8
  },
  "market": {
    "ma20": 330.1095,
    "ma50": 319.5982,
    "close": 339.03,
    "prevClose": 337.43,
    "avgVolume20": 2465425,
    "volumeRatio": 0.75,
    "changePercent": 0.47
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 8,
    "details": {
      "ret_5d": 0.04092719862059546,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 8,
      "vcp_bonus": 0,
      "vol_ratio": 0.7356058915420665,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 0.7858583919245937,
      "volat_points": 0,
      "day_range_pct": 0.0220039230215731,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 76.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 70,
        "contribution": 3.5
      },
      {
        "raw": 14,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 70,
        "contribution": 14
      },
      {
        "raw": 7.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 52,
        "contribution": 7.8
      },
      {
        "raw": 10,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 6.5,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 65,
        "contribution": 6.5
      },
      {
        "raw": 19,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 63.33,
        "contribution": 19
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "謹慎買入",
    "result": 68.8,
    "details": [
      "基本面分析總分: 3.5/5分",
      "資金流分析總分: 14/20分",
      "市場環境分析總分: 7.8/15分",
      "催化劑分析: 10/20分",
      "風險管理總分: 6.5/10分",
      "技術信號分析總分: 19/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 10,
      "基本面": 3.5,
      "資金流": 14,
      "市場環境": 7.8,
      "情緒分析": 8,
      "技術信號": 19,
      "風險管理": 6.5
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 10,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 2
            }
          },
          "catalystPoints": 10
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.6,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 625.8154751540999,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.SYK",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 700.3394962,
                "ma50": 714.56740032,
                "name": "QQQ",
                "close": 723.030029,
                "points": 1.4
              },
              "spy": {
                "ma20": 750.17250065,
                "ma50": 747.18900276,
                "name": "SPY",
                "close": 773.26001,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.452290367968293,
          "atrPoints": 2,
          "cciPoints": 2.4,
          "vixPoints": 0,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 7,
              "sentimentScoreRaw": 2.1
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141104957,
                "url": "https://finnhub.io/api/news?id=9849996268e6ca0377aecd342af41d4b51c2d6d2acf14fa9f72988951fdbab6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "CEO Lobo discusses 9% organic sales growth and margin expansion amid cybersecurity recovery.",
                "category": "company",
                "datetime": 1785802582,
                "headline": "Stryker (SYK) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141097760,
                "url": "https://finnhub.io/api/news?id=80e1dd08af4122889d88473a16bce0918659f15f36bd69017922b57bb9b5f136",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Discover why Stryker (SYK) passes a dividend screen: sustainable 1.01% yield, 7.89% growth, 38.99% payout, strong profitability. Health rating meets bar.",
                "category": "company",
                "datetime": 1785750053,
                "headline": "Stryker (NYSE:SYK): A Dividend Quality Play Built on Sustainability"
              },
              {
                "id": 141090573,
                "url": "https://finnhub.io/api/news?id=9dbefeaf373d9024ee65846476362487848dd3b3f07e6fe8bb7dabe7667947ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (SYK) is back in focus after its second quarter 2026 earnings, reporting sales of US$6.59b and net income of US$1.28b, alongside a sharp market reaction to the release. See our latest analysis for Stryker. The 1 day share price return of Stryker fell 6.42% on the earnings release, which pulled the year to date share price return down 6.46%, while the 5 year total shareholder return of 30.66% still reflects longer term gains. If Stryker’s move has you reassessing healthcare exposure,...",
                "category": "company",
                "datetime": 1785633074,
                "headline": "Is Stryker (SYK) Undervalued As Earnings Trigger A Fresh Valuation Question?"
              },
              {
                "id": 141088416,
                "url": "https://finnhub.io/api/news?id=54578ceeaf964b6f31c57ee7cdaffbe27b14fd3400769e823cb4e53c7b4dfe57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker Corporation’s recently reported Q2 2026 results showed sales rising to US$6,589 million and net income to US$1,276 million, with both basic and diluted EPS from continuing operations increasing compared with the prior year period. Management also highlighted 9% organic sales growth, recovery progress after a March cyberattack that disrupted operations, and a slight increase to full-year adjusted EPS guidance while planning to resume share repurchases. We will now examine how this...",
                "category": "company",
                "datetime": 1785600733,
                "headline": "How Strong Q2 Earnings, Raised Guidance and Cyber Recovery Will Impact Stryker (SYK) Investors"
              },
              {
                "id": 141084897,
                "url": "https://finnhub.io/api/news?id=b6978582991385153a02d491825539798caf4e831e99c586ea1b284895d2bece",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share was 5.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785555117,
                "headline": "SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion"
              },
              {
                "id": 141079101,
                "url": "https://finnhub.io/api/news?id=6e1444ccc3ac0c6ab45925f0bd4567205c2db2067d2d5fb848c2ee757ad501eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results that showed revenue that only met Wall Street's expectations and organic sales growth that missed forecasts.",
                "category": "company",
                "datetime": 1785511437,
                "headline": "Why Stryker (SYK) Shares Are Plunging Today"
              },
              {
                "id": 141079102,
                "url": "https://finnhub.io/api/news?id=693d7da201dd6ee1737f170709fd5edad838d6fb56b43a75a77dcfa9ba5d0007",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.",
                "category": "company",
                "datetime": 1785504660,
                "headline": "SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery"
              },
              {
                "id": 141075609,
                "url": "https://finnhub.io/api/news?id=3d725f68363f48a7fdbf65bd22e09ddad123f3e16ed50064ac1689cb30755331",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker Corp (SYK) delivers robust Q2 2026 results with 17.9% adjusted EPS growth, while navigating supply disruptions and narrowing full-year guidance.",
                "category": "company",
                "datetime": 1785474263,
                "headline": "Stryker Corp (SYK) (Q2 2026) Earnings Call Highlights: Strong 9% Organic Growth and Raised ..."
              }
            ],
            "raw_source": [
              {
                "id": 141157889,
                "url": "https://finnhub.io/api/news?id=c0352c42a3ef8e0c8c3348709ded75f12dd8c95242bad3e9a9ae7d785e605ddc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Intuitive Surgical has shed a third of its value while its robotic surgery peers barely flinched, and Wall Street's most bullish analyst sees an outcome that would leave anyone who sold near the bottom regretting it.",
                "category": "company",
                "datetime": 1786187149,
                "headline": "The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%"
              },
              {
                "id": 141160407,
                "url": "https://finnhub.io/api/news?id=528a84599182908bd0e04f9d3370d0a4f48c0d445d276e45da45e040f2621304",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.02% on an annualized basis producing an average annual return of 10.41%. Currently, Stryker has a market capitalization of $129.84 billion.",
                "category": "company",
                "datetime": 1786122932,
                "headline": "If You Invested $100 In Stryker Stock 20 Years Ago, You Would Have This Much Today"
              },
              {
                "id": 141121339,
                "url": "https://finnhub.io/api/news?id=f77b1271cdec6b5d0601f6c02a1fb264886f20ef1e4571a81b76f197cf0e91d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer",
                "category": "company",
                "datetime": 1785936840,
                "headline": "Stryker declares an $0.88 per share quarterly dividend"
              },
              {
                "id": 141104957,
                "url": "https://finnhub.io/api/news?id=9849996268e6ca0377aecd342af41d4b51c2d6d2acf14fa9f72988951fdbab6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "CEO Lobo discusses 9% organic sales growth and margin expansion amid cybersecurity recovery.",
                "category": "company",
                "datetime": 1785802582,
                "headline": "Stryker (SYK) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 139932823,
                "url": "https://finnhub.io/api/news?id=d08bec2c986ad84c660e7b6cf19364768850055926e7b5b30c3a247ae5aa2883",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1785766428,
                "headline": "Intuitive Surgical shares are trading higher after the company reported better-than-expected Q1 financial results."
              },
              {
                "id": 141101827,
                "url": "https://finnhub.io/api/news?id=d68930e6e25991562657a9574754249d8201846073976719a9fff78b25c57d9b",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Citizens  analyst David Turkaly   maintains Stryker (NYSE:SYK) with a Market Outperform and lowers the price target from $440 to $400.",
                "category": "company",
                "datetime": 1785751744,
                "headline": "Citizens Maintains Market Outperform on Stryker, Lowers Price Target to $400"
              },
              {
                "id": 141097760,
                "url": "https://finnhub.io/api/news?id=80e1dd08af4122889d88473a16bce0918659f15f36bd69017922b57bb9b5f136",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Discover why Stryker (SYK) passes a dividend screen: sustainable 1.01% yield, 7.89% growth, 38.99% payout, strong profitability. Health rating meets bar.",
                "category": "company",
                "datetime": 1785750053,
                "headline": "Stryker (NYSE:SYK): A Dividend Quality Play Built on Sustainability"
              },
              {
                "id": 141093867,
                "url": "https://finnhub.io/api/news?id=f313d2251dc4aeb66a33544f649f0fbe55f30728f01035fcaef9d6a2fa471782",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed current Controller and Chief Accounting Officer Mary Wilcox following her retirement. Zieselman brings experience from Surgery Partners Inc., Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya Inc., and is a licensed CPA. Solventum enters this leadership change with its stock at $85.44 and a value score of 5, which can help...",
                "category": "company",
                "datetime": 1785679682,
                "headline": "Solventum (SOLV) Appoints Neil Zieselman As New Chief Accounting Officer"
              },
              {
                "id": 141090573,
                "url": "https://finnhub.io/api/news?id=9dbefeaf373d9024ee65846476362487848dd3b3f07e6fe8bb7dabe7667947ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (SYK) is back in focus after its second quarter 2026 earnings, reporting sales of US$6.59b and net income of US$1.28b, alongside a sharp market reaction to the release. See our latest analysis for Stryker. The 1 day share price return of Stryker fell 6.42% on the earnings release, which pulled the year to date share price return down 6.46%, while the 5 year total shareholder return of 30.66% still reflects longer term gains. If Stryker’s move has you reassessing healthcare exposure,...",
                "category": "company",
                "datetime": 1785633074,
                "headline": "Is Stryker (SYK) Undervalued As Earnings Trigger A Fresh Valuation Question?"
              },
              {
                "id": 141088416,
                "url": "https://finnhub.io/api/news?id=54578ceeaf964b6f31c57ee7cdaffbe27b14fd3400769e823cb4e53c7b4dfe57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker Corporation’s recently reported Q2 2026 results showed sales rising to US$6,589 million and net income to US$1,276 million, with both basic and diluted EPS from continuing operations increasing compared with the prior year period. Management also highlighted 9% organic sales growth, recovery progress after a March cyberattack that disrupted operations, and a slight increase to full-year adjusted EPS guidance while planning to resume share repurchases. We will now examine how this...",
                "category": "company",
                "datetime": 1785600733,
                "headline": "How Strong Q2 Earnings, Raised Guidance and Cyber Recovery Will Impact Stryker (SYK) Investors"
              },
              {
                "id": 141084897,
                "url": "https://finnhub.io/api/news?id=b6978582991385153a02d491825539798caf4e831e99c586ea1b284895d2bece",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share was 5.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785555117,
                "headline": "SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion"
              },
              {
                "id": 141084898,
                "url": "https://finnhub.io/api/news?id=f664948358320b7072ec63f7a4f232d5cb083af6b12cdfe5111e88f186be9a04",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) reported 9% organic sales growth in the second quarter of 2026 and adjusted earnings per share growth of 17.9%, as the medical technology company continued recovering from a cybersecurity incident that disrupted operations earlier in the year. Chair and CEO Kevin Lobo said the co",
                "category": "company",
                "datetime": 1785553419,
                "headline": "Stryker Q2 Earnings Call Highlights"
              },
              {
                "id": 141081084,
                "url": "https://finnhub.io/api/news?id=70bbcce77128ce60408559bc0eff0eb1c5a69e0b368ceaf48afb23f8f90d3659",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.",
                "category": "company",
                "datetime": 1785524701,
                "headline": "Stay informed with the top movers within the S&P500 index on Friday."
              },
              {
                "id": 141079654,
                "url": "https://finnhub.io/api/news?id=dc3ff60c01a4cba8c16b37a9d68c917c01a4881bda5a38ec734feab622f76ce3",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.",
                "category": "company",
                "datetime": 1785515701,
                "headline": "Friday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 141088034,
                "url": "https://finnhub.io/api/news?id=091e291322d839a74e3ff99817f04cbc67876f2b1099f6fc55fe8b4d55ef1aad",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "RBC Capital  analyst Kendall Au   maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $435 to $420.",
                "category": "company",
                "datetime": 1785512976,
                "headline": "RBC Capital Maintains Outperform on Stryker, Lowers Price Target to $420"
              },
              {
                "id": 141079101,
                "url": "https://finnhub.io/api/news?id=6e1444ccc3ac0c6ab45925f0bd4567205c2db2067d2d5fb848c2ee757ad501eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results that showed revenue that only met Wall Street's expectations and organic sales growth that missed forecasts.",
                "category": "company",
                "datetime": 1785511437,
                "headline": "Why Stryker (SYK) Shares Are Plunging Today"
              },
              {
                "id": 141088035,
                "url": "https://finnhub.io/api/news?id=e2e2d816fb0ebe46d62fd30241fd1096e427f4fdb38399f659a7ed60c09124cc",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "JP Morgan  analyst Robbie Marcus   maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $400 to $350.",
                "category": "company",
                "datetime": 1785508582,
                "headline": "JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $350"
              },
              {
                "id": 141078388,
                "url": "https://finnhub.io/api/news?id=709f67f86ab747d0315d9411a2d452a1aa73a192bfaa79693c1ad37daa9e1c90",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Let's have a look at the S&P500 gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1785508501,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 141079102,
                "url": "https://finnhub.io/api/news?id=693d7da201dd6ee1737f170709fd5edad838d6fb56b43a75a77dcfa9ba5d0007",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.",
                "category": "company",
                "datetime": 1785504660,
                "headline": "SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery"
              },
              {
                "id": 141077642,
                "url": "https://finnhub.io/api/news?id=3223cbf246df2f33c69539037f774a50260cd33d10286f045a518ad8062cad57",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Discover the top S&P500 movers in Friday's pre-market session and stay informed about market dynamics.",
                "category": "company",
                "datetime": 1785501301,
                "headline": "Get insights into the top movers in the S&P500 index of Friday's pre-market session."
              },
              {
                "id": 141080377,
                "url": "https://finnhub.io/api/news?id=ebf5302d3fb61d848b9318d2fb7161d75f2dfb97d79c0c3fcbc56679c65157a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.",
                "category": "company",
                "datetime": 1785498800,
                "headline": "Stryker catching up on orders, manufacturing after cyberattack"
              },
              {
                "id": 141077283,
                "url": "https://finnhub.io/api/news?id=b5d6ed3a1f9c19e6aa2d7ed38d14a89d15abccf4e60653931114cbaf20826ee9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker was hit by a cyberattack that disrupted its global operations in March 2026.",
                "category": "company",
                "datetime": 1785497028,
                "headline": "Stryker nets $6.6bn revenue in Q2; highlights resilience following cyberattack"
              },
              {
                "id": 141088036,
                "url": "https://finnhub.io/api/news?id=1b5ab335d27aff234262b61781f47c128f6b86ebac32369030c8041cc039064b",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Piper Sandler  analyst Matt O'Brien   maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $420 to $390.",
                "category": "company",
                "datetime": 1785495130,
                "headline": "Piper Sandler Maintains Overweight on Stryker, Lowers Price Target to $390"
              },
              {
                "id": 141078468,
                "url": "https://finnhub.io/api/news?id=f9384096c9e2ec130648bc3a76d285228a71b0c2a31d7243ff37ac4708154cff",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Truist Securities  analyst Richard Newitter   maintains Stryker (NYSE:SYK) with a Hold and raises the price target from $330 to $340.",
                "category": "company",
                "datetime": 1785490094,
                "headline": "Truist Securities Maintains Hold on Stryker, Raises Price Target to $340"
              },
              {
                "id": 141078421,
                "url": "https://finnhub.io/api/news?id=6dc628efceee58f8f06074c12188171787de522b940387d97752b47b6745b3a6",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/31/Cupertino--California--September-25--202.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.",
                "category": "company",
                "datetime": 1785484996,
                "headline": "Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session"
              },
              {
                "id": 141078470,
                "url": "https://finnhub.io/api/news?id=acf0bbaa6753c43c4b00ed1d1b6791d23dfcd48e79c29b5eed422e206ecf7914",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "BTIG  analyst Ryan Zimmerman   maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $371 to $358.",
                "category": "company",
                "datetime": 1785476106,
                "headline": "BTIG Maintains Buy on Stryker, Lowers Price Target to $358"
              },
              {
                "id": 141075609,
                "url": "https://finnhub.io/api/news?id=3d725f68363f48a7fdbf65bd22e09ddad123f3e16ed50064ac1689cb30755331",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker Corp (SYK) delivers robust Q2 2026 results with 17.9% adjusted EPS growth, while navigating supply disruptions and narrowing full-year guidance.",
                "category": "company",
                "datetime": 1785474263,
                "headline": "Stryker Corp (SYK) (Q2 2026) Earnings Call Highlights: Strong 9% Organic Growth and Raised ..."
              },
              {
                "id": 141072966,
                "url": "https://finnhub.io/api/news?id=f94904855a6beaf664103c9538e9891d54fcd035cad74bffa4c28a3ca723c1a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785448803,
                "headline": "Stryker (SYK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates"
              },
              {
                "id": 141073948,
                "url": "https://finnhub.io/api/news?id=2bf87100b0be4ace6f9bb6fd5739de24834776b90e8c0a9111f2ff1feb67b47f",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SYK",
                "summary": "Stryker Corporation (SYK) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDTCompany ParticipantsKevin Lobo - Chairman & CEONick Mead - Vice President of...",
                "category": "company",
                "datetime": 1785447195,
                "headline": "Stryker Corporation (SYK) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141072967,
                "url": "https://finnhub.io/api/news?id=b87882a1733a32a94b94a807ef31827915068c20b41d6dc80024bd57afa87e23",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (SYK) delivered earnings and revenue surprises of +6.65% and +0.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785446704,
                "headline": "Stryker (SYK) Q2 Earnings and Revenues Beat Estimates"
              },
              {
                "id": 141070794,
                "url": "https://finnhub.io/api/news?id=f8d1c849bf50f0e7ed2bab5907315b69ff748fb261be59d615f88c9467b4b9f8",
                "image": "https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.",
                "category": "company",
                "datetime": 1785445501,
                "headline": "Which S&P500 stocks are moving after the closing bell on Thursday?"
              },
              {
                "id": 141070567,
                "url": "https://finnhub.io/api/news?id=271cbe3ae8d42a3003c39cf6da1cc6ad0b18ff06988b4893fe364cbc7d9a5942",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Stryker Q2 revenue slightly missed estimates but EPS beat; stock fell 9% after-hours amid cyber incident concerns and cautious guidance.",
                "category": "company",
                "datetime": 1785444645,
                "headline": "Stryker (NYSE:SYK) Slips After Q2 Revenue Miss Overshadows Earnings Beat"
              },
              {
                "id": 141071596,
                "url": "https://finnhub.io/api/news?id=181d14fca24c844c0535538d46d9f10d945ae93483bddf6995e50545afce60f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share was 5.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785443414,
                "headline": "Stryker (NYSE:SYK) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops"
              },
              {
                "id": 141071597,
                "url": "https://finnhub.io/api/news?id=7e11a7d9de1cf122d6661916577ca95d4a22b4502ce141e5a52136cb22075bbd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026: Second Quarter Results Reported net sales increased 9.4% to $6.6 billionOrganic net sales increased 9.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 170 bps to 27.4%Reported EPS increased 44.1% to $3.30Adjusted EPS(1) increased 17.9% to $3.69 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant",
                "category": "company",
                "datetime": 1785441900,
                "headline": "Stryker reports second quarter 2026 operating results"
              },
              {
                "id": 141068403,
                "url": "https://finnhub.io/api/news?id=f5572ddf3d22d2845f8b0c8b91feb2a909850029630299420001508aaac54c05",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "ISRG is expanding robotic surgery beyond urology as general surgery and newer specialties gain traction, creating fresh avenues for long-term procedure growth.",
                "category": "company",
                "datetime": 1785429600,
                "headline": "Is ISRG Winning the Next Phase of Robotic Surgery Beyond Urology?"
              },
              {
                "id": 141071249,
                "url": "https://finnhub.io/api/news?id=a6946338722c8fc35da0ad5310a5e929c6886df7814ca18e27bd62ab94a390a1",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) raises FY2026 Adj EPS guidance from $14.90-$15.10 to $14.95-$15.10 vs $14.97 analyst estimate..",
                "category": "company",
                "datetime": 1785427679,
                "headline": "Stryker Raises FY2026 Adj EPS Guidance from $14.90-$15.10 to $14.95-$15.10 vs $14.97 Est"
              },
              {
                "id": 141071250,
                "url": "https://finnhub.io/api/news?id=37195837c6896f9236190eb1358fbe628e01030bb2ee25e091e7c8fbf2cc4469",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) reported quarterly earnings of $3.69 per share which beat the analyst consensus estimate of $3.49 by 5.73 percent. This is a 17.89 percent increase over earnings of $3.13 per share from the same",
                "category": "company",
                "datetime": 1785427605,
                "headline": "Correction: Stryker Q2 Adj. EPS $3.69 Beats $3.49 Estimate, Sales $6.589B Beat $6.579B Estimate"
              },
              {
                "id": 141054603,
                "url": "https://finnhub.io/api/news?id=2e1b398d579004081a531279f8ffac40f3827759c8104cd232f4e15a44ec2b33",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.",
                "category": "company",
                "datetime": 1785336840,
                "headline": "Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?"
              },
              {
                "id": 141053281,
                "url": "https://finnhub.io/api/news?id=c8e5fec55ce152c1ae6354957dc3bbd151dcbca6a9ba72d322bff0b1a932d8bb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "In the world of robotic surgery, one company is both the undisputed leader and the most expensive name on the shelf, forcing investors to ask if operational brilliance is worth the high price of admission.",
                "category": "company",
                "datetime": 1785332790,
                "headline": "The Best House On The Block Costs The Most: ISRG"
              },
              {
                "id": 141043786,
                "url": "https://finnhub.io/api/news?id=53a07b3ea70afe32c66792b42633c5e5ab98f3c0d30d426365765b844c8aa997",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker has introduced Mako RPS, a robotic handheld system for total knee replacement, expanding its Mako robotics portfolio. The launch extends robotic assistance to a wider range of orthopaedic procedures and care settings. The development highlights Stryker's focus on robotic-assisted surgery and surgeon flexibility in knee replacement. Stryker, traded as NYSE:SYK, is drawing attention with the launch of Mako RPS alongside a share price of $336.74. The stock is up 5.5% over the past week...",
                "category": "company",
                "datetime": 1785247667,
                "headline": "Stryker (SYK) Launches Mako RPS To Bring Robotic Knee Surgery To More Surgeons"
              },
              {
                "id": 141042348,
                "url": "https://finnhub.io/api/news?id=56f2f285ff59a3a37ef0ce4aefbadc33ee3bcdb7f56f7c7e94741a06e3cf8529",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Intuitive Surgical (NASDAQ:ISRG) trades at $356.83, while the average Wall Street price target sits at $484.40. That leaves roughly a 36% gap between current price and Street consensus. Intuitive builds the da Vinci robotic surgery platform and the Ion lung biopsy system, dominating soft tissue surgical robotics. Wall Street has debated whether that moat holds ... Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685",
                "category": "company",
                "datetime": 1785246435,
                "headline": "Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685"
              },
              {
                "id": 141042644,
                "url": "https://finnhub.io/api/news?id=7507ca35b1cbe8e76ab6c5b9c089fdd29418dcb58a04e57f6822f7749625c588",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1785245664,
                "headline": "Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141035129,
                "url": "https://finnhub.io/api/news?id=c92ef4a473af545abf93085c0feb833d345113b7ee6e12a65912c65c41f0d0ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.",
                "category": "company",
                "datetime": 1785167220,
                "headline": "J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?"
              },
              {
                "id": 141035262,
                "url": "https://finnhub.io/api/news?id=3647e16ddb54bcb74608f6e6fedc1a1a9698d86be7c61a3e3fdbb16221dff9ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "PAHC vs. SYK: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1785166802,
                "headline": "PAHC vs. SYK: Which Stock Is the Better Value Option?"
              },
              {
                "id": 141033951,
                "url": "https://finnhub.io/api/news?id=fcecda06d78a64160b71a7c83b72c3f8c835a6e8f5af835e1d1b85f851c8ee0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785158111,
                "headline": "Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS"
              },
              {
                "id": 141033952,
                "url": "https://finnhub.io/api/news?id=e1356cc922d24b2065e4fc35f5b4985c2626ea5c847c8e830a021f485c0ba596",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure demand as investors watch for earnings and margin trends.",
                "category": "company",
                "datetime": 1785157260,
                "headline": "Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders"
              },
              {
                "id": 141011008,
                "url": "https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SYK",
                "summary": "Get the weekly dividend update for Champions, Contenders & Challengers—read about the dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1784916411,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"
              },
              {
                "id": 141005276,
                "url": "https://finnhub.io/api/news?id=fce891feb90878c9b568365dc8ab8155bd45866a90ca9d2b3a5d6fc1f72863eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.",
                "category": "company",
                "datetime": 1784897252,
                "headline": "Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?"
              },
              {
                "id": 141017280,
                "url": "https://finnhub.io/api/news?id=76d2787cc2237b397d2f26adc0684909ea937123a4b2b20124117fe4fa5e2b68",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/24-7-2026-111735-thebambooworks-com.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses\n\n\n\n\n\n\n\nimage credit: Bamboo Works\n\n\n\nKey Takeaways:\n\n\n\n\nMicroPort MedBot",
                "category": "company",
                "datetime": 1784897088,
                "headline": "MicroPort MedBot To Report First-Ever Profit On Booming Exports"
              },
              {
                "id": 140997733,
                "url": "https://finnhub.io/api/news?id=74d97e4def4c98d768ccd094d979fd3873c5ca18e7d51d9299d8c49e4fed8b7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Qualcomm, Intuitive Surgical and Stryker lead today's top analyst reports, spotlighting growth drivers, strategic initiatives and ongoing challenges.",
                "category": "company",
                "datetime": 1784817900,
                "headline": "The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants"
              },
              {
                "id": 140988153,
                "url": "https://finnhub.io/api/news?id=f12b46768222b60cc0e5cc0ad5a8a82c6ef823fd74cb0af6ee75633f8d102550",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "QUALCOMM is expanding beyond smartphones with growth in automotive, edge AI and data centers, but competition and weak China demand remain key challenges.",
                "category": "company",
                "datetime": 1784753640,
                "headline": "Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker"
              },
              {
                "id": 140974912,
                "url": "https://finnhub.io/api/news?id=bbdead80568b813174817288369cedcdbc1558cbe69a3fa5d808987e69a9b82d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The market is offering a steep discount on this medical device maker, but the price tag comes with a story about slowing growth. Here’s how to read it.",
                "category": "company",
                "datetime": 1784660157,
                "headline": "Why BSX Stock Hands You So Much Cash Right Now"
              },
              {
                "id": 140974913,
                "url": "https://finnhub.io/api/news?id=aa203e7f28d79433427fb12950820e559672ed5b69c0e2a20f702bef68a97fcc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.",
                "category": "company",
                "datetime": 1784659383,
                "headline": "ISRG Stock: The Math Hidden In Its Price"
              },
              {
                "id": 140970510,
                "url": "https://finnhub.io/api/news?id=417bfdbec370b20b7e87a80f159cd76c2d10f705358575971728f4e520ddbf47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "NZS shifts capital toward AI infrastructure and healthcare leaders",
                "category": "company",
                "datetime": 1784636527,
                "headline": "Nvidia Returns to NZS Growth Fund"
              },
              {
                "id": 140963421,
                "url": "https://finnhub.io/api/news?id=6ea0dd033658292f48582a592a40caa31066d357172a543dd20d199c2861cc74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.",
                "category": "company",
                "datetime": 1784574905,
                "headline": "The Robot Maker's Paradox"
              },
              {
                "id": 140963423,
                "url": "https://finnhub.io/api/news?id=26047126ae59bd8c4eb72c217ec847dd194744894cd020aa98db1bbb6da3a19e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.",
                "category": "company",
                "datetime": 1784571665,
                "headline": "What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?"
              },
              {
                "id": 140958769,
                "url": "https://finnhub.io/api/news?id=1e780a5396652a26af12c43d63de943d5bbdd6ac1d228864b9cc1b0bedf0fcf1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "LARGO, Fla., July 20, 2026--CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL.",
                "category": "company",
                "datetime": 1784545200,
                "headline": "CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting"
              },
              {
                "id": 140962422,
                "url": "https://finnhub.io/api/news?id=5580413bb66938372e33afb5c6bebf77eb21224e311db5a3ece505b10699aa95",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.04% on an annualized basis producing an average annual return of 10.3%. Currently, Stryker has a market capitalization of $122.02 billion.",
                "category": "company",
                "datetime": 1784543421,
                "headline": "Here’s How Much You Would Have Made Owning Stryker Stock In The Last 20 Years"
              },
              {
                "id": 140944900,
                "url": "https://finnhub.io/api/news?id=e77d76f3434f17b44a7271a4b4178cd3a084000ccbc8170e1df151c1706c49f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while market based multiples look closer to fair. Over five years, Stryker has returned 28.3%, which points to steady but not dramatic long term gains for shareholders. New products such as the Mako RPS handheld robotic system can support expectations for future cash...",
                "category": "company",
                "datetime": 1784394439,
                "headline": "Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings"
              },
              {
                "id": 140940547,
                "url": "https://finnhub.io/api/news?id=c2585392dea75a3bc277f15d8952bba6cd6eb3516ae5a01c7312595cfaa19a1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move extends the Mako ecosystem beyond robotic-arm systems into handheld robotics, potentially broadening adoption by matching robotic precision with familiar surgical workflows. Next, we’ll explore how expanding the...",
                "category": "company",
                "datetime": 1784344509,
                "headline": "Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK)"
              },
              {
                "id": 140940111,
                "url": "https://finnhub.io/api/news?id=ebe2202ade933d00e63044350229e08b82e7db86b01a7ae08cdabb4732e1e7be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements that extends its established Mako orthopaedic robotics portfolio. See our latest analysis for Stryker. The U.S. launch of Mako RPS comes as Stryker’s share price sits at US$319.87 after a recent pullback, with a 30 day share price return of 6.22% but a 1 year total shareholder return that declined 17.02%. This suggests enthusiasm around its...",
                "category": "company",
                "datetime": 1784336914,
                "headline": "Stryker (SYK) Launches Mako RPS As Its Valuation Story Comes Into Focus"
              },
              {
                "id": 140934568,
                "url": "https://finnhub.io/api/news?id=fcdbb1523ac61c565eff444a9974ae081ef0444ebc3b4e416bbf2d2d7408ab7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.",
                "category": "company",
                "datetime": 1784302740,
                "headline": "Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio"
              },
              {
                "id": 140932973,
                "url": "https://finnhub.io/api/news?id=0504e442cf7f265bb43b0e44d54c0386af3ed0aa7fd4f592d362e90177bbdfa3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "JNJ beats Q2 estimates and raises 2026 guidance, but shares fall as MedTech misses expectations. Find out what weighed on the unit and what's next.",
                "category": "company",
                "datetime": 1784298660,
                "headline": "J&J Stock Falls Despite Strong Q2 Beat & Higher 2026 View: Here's Why"
              },
              {
                "id": 140111723,
                "url": "https://finnhub.io/api/news?id=c6a02a2441034d13c97bae14c10063c3d4dedcc3d5c1f87702392bc91f1896e7",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1784291136,
                "headline": "GE HealthCare Technologies shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS and lowered its FY2026 adjusted EPS guidance."
              },
              {
                "id": 140920976,
                "url": "https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.",
                "category": "company",
                "datetime": 1784210345,
                "headline": "Why Abbott Stock Is Reimagining Its Future"
              },
              {
                "id": 140919929,
                "url": "https://finnhub.io/api/news?id=331a94af61a8277087847eb57290e1a52ef46de16da33713fb098788bd0f19de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (NYSE: SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement procedures, further expanding the Mako portfolio into a new category of orthopaedic robotics.",
                "category": "company",
                "datetime": 1784207100,
                "headline": "Stryker expands Mako robotics portfolio with full market release of Mako RPS"
              },
              {
                "id": 140049019,
                "url": "https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1784205329,
                "headline": "Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"
              },
              {
                "id": 140912813,
                "url": "https://finnhub.io/api/news?id=af3b9436f23bb6328aa43e6b3e1faf8d7dd198364bfa6e28cf7cd911df9289f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.",
                "category": "company",
                "datetime": 1784140381,
                "headline": "The Open Questions On ISRG Stock"
              },
              {
                "id": 140911296,
                "url": "https://finnhub.io/api/news?id=aee602b293e01bdae62f2d6674938ab67845e74bf45b3536a1bd3aa55fdad064",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Johnson & Johnson stock dipped early Wednesday, though the healthcare giant beat second-quarter forecasts and raised its outlook.",
                "category": "company",
                "datetime": 1784134793,
                "headline": "J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others"
              },
              {
                "id": 140906847,
                "url": "https://finnhub.io/api/news?id=922de0113b1b98ef15feee5ce7b9d228ed7c895637d059a927c88ef957dcf758",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "When Iranian-linked hackers breached medical device maker Stryker in March 2026, they did not need a sophisticated zero-day exploit to cause chaos. Once inside, they triggered simultaneous factory resets on more than 200,000 corporate devices across 79 countries, grinding order processing, production and shipping to a halt for days. Two months later, Foxconn confirmed that the Nitrogen ransomware group had stolen an alleged 8 terabytes of data from its North American factories, including project",
                "category": "company",
                "datetime": 1784102400,
                "headline": "Independent Testing Shows Which Business Security Products Actually Hold Up When It Matters"
              },
              {
                "id": 140901598,
                "url": "https://finnhub.io/api/news?id=1c30ec9fc5eaa65b249de9077cf426329d566c616ac5f9591f0e7f9ba8098349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.",
                "category": "company",
                "datetime": 1784058057,
                "headline": "Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble"
              },
              {
                "id": 140901109,
                "url": "https://finnhub.io/api/news?id=deff9c90bb7e909239d4818d05eb00911aa88c16bd160a2315a273ea8e21cb70",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1784055900,
                "headline": "Discover which S&P500 stocks are making waves on Tuesday."
              },
              {
                "id": 140901466,
                "url": "https://finnhub.io/api/news?id=3b28393a5831026f9ac3732237381ea888082eee864a93bb498cf961a423a22f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.",
                "category": "company",
                "datetime": 1784052407,
                "headline": "The Paid-To-Hold Play On ISRG Stock: A 12% Income"
              },
              {
                "id": 140898964,
                "url": "https://finnhub.io/api/news?id=76a3fb9d03f8bf894bf401ec3d9d7e7a7980e4769b9be8dd004e0986d25fa30d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.",
                "category": "company",
                "datetime": 1784046901,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 140897584,
                "url": "https://finnhub.io/api/news?id=e89def7c0ac59e2c2278d3bdc4ee12a87bb928101e8b6a227c378a65a8572717",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.",
                "category": "company",
                "datetime": 1784039701,
                "headline": "What's going on in today's session: S&P500 gap up and gap down stocks"
              },
              {
                "id": 140091407,
                "url": "https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1784034450,
                "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"
              },
              {
                "id": 140896860,
                "url": "https://finnhub.io/api/news?id=69cac81872a917b82ac0a4526f38f4b08928a2ae81ab419989126f3ac804ca95",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.",
                "category": "company",
                "datetime": 1784033543,
                "headline": "ISRG Stock: What Does Its Valuation Imply?"
              },
              {
                "id": 140885071,
                "url": "https://finnhub.io/api/news?id=71b31314daf117ab4b7a113eb37cfe524f5210f5754749ce4767d53f3ef0320c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Opportunities in the nerve repair biomaterials market include advancements in regenerative medicine, rising demand for minimally invasive procedures, and smart biomaterials integration. Growth is driven by increased traumatic brain injuries, aging populations, and regional expansion, especially in Asia-Pacific. Nerve Repair Biomaterials Market Nerve Repair Biomaterials Market Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The \"Nerve Repair Biomaterials Market Report 2026\" has been added to ResearchAn",
                "category": "company",
                "datetime": 1783942080,
                "headline": "Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players"
              },
              {
                "id": 140865362,
                "url": "https://finnhub.io/api/news?id=190546a100126c6d960166a6da62d4ab071710c348633046d16e808216573c23",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.",
                "category": "company",
                "datetime": 1783707000,
                "headline": "ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?"
              },
              {
                "id": 140857121,
                "url": "https://finnhub.io/api/news?id=d5da76e3d463a1659eb229b2fb369439662f69c42499cdfd038f9ac17e2e5543",
                "image": "",
                "source": "Fintel",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1783645922,
                "headline": "BMO Capital Initiates Coverage of Stryker (SYK) with Outperform Recommendation"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 7,
            "recomputed_at_score": true,
            "sentiment_score_raw": 2.1,
            "source_article_count": 80,
            "discarded_article_count": 60
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日2日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 2608973.3333333335,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2599790,
              "avg_vol_20": 2509360,
              "avg_vol_30": 2608973.3333333335,
              "range_pct_10": 0.10285222577014483,
              "range_pct_20": 0.13556319539734893,
              "range_pct_30": 0.13556319539734893,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9964800968963525,
              "dist_to_20d_high": 0.03818545598982826,
              "down_shrink_days": 0,
              "breakout_level_20d": 352.48999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.7587031676899836
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.452290367968293,
              "turnoverUsdM": 625.8154751540999,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.SYK",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 315.6214,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 6.9,
            "take_profit_price": 365.7158,
            "target_multiplier": 1.9,
            "technical_strength": 1.8,
            "take_profit_percent": 7.9
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.904580735936586,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.SYK",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 11.7043,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.45
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 49.85
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1479
    },
    "kdj": {
      "d": 64.89,
      "j": 55.62,
      "k": 61.8,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 47.52
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 19153100,
      "recentSlope": 243350,
      "previousSlope": 26930
    },
    "rsi": 59.63,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 324.279,
      "position": "SAR喺價下",
      "distancePct": 4.35,
      "previousTrend": "上升"
    },
    "ma50": 319.5982,
    "macd": {
      "macd": 5.594883682018576,
      "trend": "強烈看漲",
      "signal": 5.488380197931834,
      "histogram": 0.10650348408674226
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 329.1212,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 5
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.75,
      "score": 2,
      "avgVolume": 2465425,
      "currentVolume": 1845900
    },
    "derived": {
      "ma20": 330.1095,
      "ma50": 319.5982,
      "prevClose": 337.43,
      "avgVolume10": 2547120,
      "avgVolume20": 2465425,
      "changePercent": 0.47,
      "avgVolumeForScore": 2465425
    },
    "ma_cross": {
      "ma20": 330.1095,
      "ma50": 319.5982,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 329.647,
      "prevMa50": 318.9364,
      "spreadPct": 3.29,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 305.3561,
      "upper": 354.8629,
      "position": "上半部"
    },
    "rsi_short": 40.24,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.75
    }
  }
}

Raw metrics JSON

 
{
  "close": 339.03,
  "volume": 1845900,
  "changePercent": 0.47
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.